Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale …
…, SH Cheng, WC Ko, KP Hwang, NC Wang… - The Lancet …, 2021 - thelancet.com
Background MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised
spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown …
spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown …
A novel mechanism underlies the hepatotoxicity of pyrazinamide
…, CY Pai, P Yang, WL Chang, NC Wang… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Relatively little is known about the hepatotoxicity of pyrazinamide (PZA). PZA requires activation
by amidase to form pyrazinoic acid (PA). Xanthine oxidase then hydroxylates PA to form …
by amidase to form pyrazinoic acid (PA). Xanthine oxidase then hydroxylates PA to form …
Risk Factors for Healthcare-Associated Extensively Drug-Resistant Acinetobacter baumannii Infections: A Case-Control Study
The emergence of extensively drug-resistant Acinetobacter baumannii (XDRAB) is a
serious threat to hospitalized patients. From 2008 to 2010, surveillance detected 25 hospital-…
serious threat to hospitalized patients. From 2008 to 2010, surveillance detected 25 hospital-…
[PDF][PDF] Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis
YY Chou, TY Lin, JC Lin, NC Wang, MY Peng… - J Microbiol Immunol …, 2008 - sociedad-iih.cl
Background and Purpose: Vancomycin-resistant enterococci (VRE) have emerged as
important nosocomial pathogens. This study was conducted to clarify the clinical features and …
important nosocomial pathogens. This study was conducted to clarify the clinical features and …
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment …
…, MS Tsai, CE Liu, YT Lee, HJ Tang, NC Wang… - PLoS …, 2017 - journals.plos.org
Objectives The international and national HIV treatment guidelines in 2016 have focused on
scaling up access to combination antiretroviral therapy (cART). We aimed to assess the …
scaling up access to combination antiretroviral therapy (cART). We aimed to assess the …
Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score≥ 15
HF Hsieh, TW Chen, CY Yu, NC Wang, HC Chu… - The American journal of …, 2008 - Elsevier
BACKGROUND: Most liver abscesses resolve after antimicrobial therapy or percutaneous
tube drainage (PD). The aim of this study was to evaluate the results of hepatic resection (HR) …
tube drainage (PD). The aim of this study was to evaluate the results of hepatic resection (HR) …
Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
TY Lin, KM Yeh, JC Lin, NC Wang… - … , and infection= Wei …, 2009 - europepmc.org
Background and purpose Cryptococcus neoformans is an encapsulated pathogenic yeast
that causes a wide range of clinical manifestations. The serum cryptococcal latex …
that causes a wide range of clinical manifestations. The serum cryptococcal latex …
[HTML][HTML] Quantification and comparison of virulence and characteristics of different variants of carbapenemase-producing Klebsiella pneumoniae clinical isolates from …
…, YS Yang, KM Yeh, SK Chiu, NC Wang… - Journal of Microbiology …, 2016 - Elsevier
Background/purpose The emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing
strains is a challenge for clinicians. The characteristics and virulence of variants of …
strains is a challenge for clinicians. The characteristics and virulence of variants of …
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review
…, JC Lin, SJ Ho, YS Yang, FY Chang, NC Wang - Journal of Microbiology …, 2010 - Elsevier
BACKGROUND/PURPOSE: The yeast Kodamaea ohmeri rarely causes life-threatening
human infections. However, risk factors, laboratory diagnoses, and treatments for K. ohmeri …
human infections. However, risk factors, laboratory diagnoses, and treatments for K. ohmeri …
[HTML][HTML] Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia …
CH Wang, JC Lin, HA Lin, FY Chang, NC Wang… - Journal of Microbiology …, 2016 - Elsevier
Background/purpose The impact of bacteremia due to the resistance of Stenotrophomonas
maltophilia to trimethoprim–sulfamethoxazole (TMP–SXT) is uncertain. This study compared …
maltophilia to trimethoprim–sulfamethoxazole (TMP–SXT) is uncertain. This study compared …
